![Justin Ward](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Vermogen: 110 882 $ op 31-07-2026
Justin Ward is currently the Executive Director & Manager-Quality Assurance at Recce Pharmaceuticals Ltd. He previously worked as a Laboratory Manager at Solbec Pharmaceuticals Ltd. and as a Quality Manager at Phebra Pty Ltd.
| Onderneming | Datum | Aantal aandelen | Totale waarde | Waarderingsdatum |
|---|---|---|---|---|
| 31-07-2026 | 426.684 ( 0,14% ) | 110 882 $ | 31-07-2026 |
| Bedrijven | Functie | Begin |
|---|---|---|
| RECCE PHARMACEUTICALS LTD | Directeur/Bestuurslid | 09-07-2019 |
| Bedrijven | Functie | Einde |
|---|---|---|
Phebra Pty Ltd.
 Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies sterile injectable pharmaceutical products | Corporate Officer/Principal | - |
Solbec Pharmaceuticals Ltd.
 Solbec Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops and markets therapies for life threatening and debilitating diseases | Corporate Officer/Principal | - |
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Eerstegraads connecties
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
| Bedrijven in privébezit | 3 |
|---|---|
Solbec Pharmaceuticals Ltd.
Solbec Pharmaceuticals Ltd. BiotechnologyHealth Technology Develops and markets therapies for life threatening and debilitating diseases | Health Technology |
Phebra Pty Ltd.
Phebra Pty Ltd. Pharmaceuticals: MajorHealth Technology Manufactures and supplies sterile injectable pharmaceutical products | Health Technology |
Recce Pharmaceuticals Ltd.
 Recce Pharmaceuticals Ltd. Pharmaceuticals: MajorHealth Technology Creates and manufactures antibiotics | Health Technology |
Kies jouw editie
Alle financiële informatie op nationaal niveau
